drugset / Trial / NCT02237443
Mask Ventilation Before and After Neuromuscular Blockade
NaSingle-groupOpen-labelTreatment
Summary
Anesthesia providers are taught to "test" that they can properly ventilate a patient's lungs before administering a neuromuscular blocking drug (NMBD), rendering the patient apneic. This is a traditional teaching, not based on empirical evidence. The investigators primary hypothesis is that ventilation after the administration of NMBDs is non-inferior with that before their administration with respect to the composite safety endpoint of inadequate (MVi) and dead-space only (Vds) ventilation.
Timeline
- Start
- 2014-08
- Primary completion
- 2014-11
- Completion
- 2015-02
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Rocuronium | Other / unclassified | — | — |
| Subject | Suxamethonium | Other / unclassified | — | — |
| Subject | Vecuronium | Small molecule | — | — |
Indications
No indication recorded.